Colchicine for Amyotrophic Lateral Sclerosis (Co-ALS)
Colchicine for Amyotrophic Lateral Sclerosis: a Phase II, Randomized, Double Blind, Placebo Controlled, Multicenter Clinical Trial
Sponsor: Azienda Ospedaliero-Universitaria di Modena
A PHASE2 clinical study on Amyotrophic Lateral Sclerosis, this trial is completed. The trial is conducted by Azienda Ospedaliero-Universitaria di Modena and has accumulated 12 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Apr 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Sep 2022 — Apr 2023 [monthly]
Active Not Recruiting PHASE2
▶ Show 7 earlier versions
-
Apr 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
-
Sep 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Feb 2019 — Mar 2020 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Not Yet Recruiting PHASE2
-
Nov 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliero-Universitaria di Modena
- Catholic University of the Sacred Heart
- IRCCS National Neurological Institute C. Mondino Foundation
- IRCCS San Raffaele
- Istituto Auxologico Italiano
- Istituto Di Ricerche Farmacologiche Mario Negri
- University of Bari
- University of Campania Luigi Vanvitelli
- University of Milan
- University of Modena and Reggio Emilia
- University of Padova
- University of Turin, Italy
For direct contact, visit the study record on ClinicalTrials.gov .